23:32

Øystein Fluge | International ME/CFS Conference 2025: Plasma cell targeting by daratumumab in ME/CFS

14:00

David Putrino | International ME/CFS Conference 2025: Low-dose Rapamycin for Long COVID

11:53

David Systrom | International ME/CFS Conference 2025: LDN and Mestinon in ME/CFS and Long COVID

18:59

Michael Peluso | International ME/CFS Conference 2025: Viral persistence in Post-COVID Syndromes

14:34

Alan Cash | International ME/CFS Conference 2025: Anhydrous Enol-Oxaloacetate Treatment of ME/CFS

14:17

Laura Kim | International ME/CFS Conference 2025: Hyperbaric Oxygen Therapy (HBOT) in ME/CFS

13:53

Nina Babel | International ME/CFS Conference 2025: IgG therapy in ME/CFS and Post-COVID Syndrome

11:28

Georg Schlieper | International ME/CFS Conference 2025: Immunoadsorption in severe ME/CFS patients

11:40

Elisa Stein | International ME/CFS Conference 2025: Efficacy of repeated immunoadsorption in ME/CFS

09:38

Wakiro Sato | International ME/CFS Conference 2025: Rituximab trial in Japan

18:44

Olav Mella | International ME/CFS Conference 2025: Drug treatment - What have we learned since 2007?

18:17

Birgit Sawitzki | International ME/CFS Conference 2025: T and B cell responses in ME/CFS

18:43

Christiana Franke | International ME/CFS Conference 2025: Autoantibodies to neuronal antigens

19:10

Franziska Sotzny | International ME/CFS Conference 2025: Autoantibodies mimicking EBV sequences

15:48

Takashi Yamamura | International ME/CFS Conference 2025: GPCR autoantibodies and brain alterations

20:17

Jeroen den Dunnen | International ME/CFS Conference 2025: Autoimmunity as a cause of ME/CFS

11:32

Karl Johan Tronstad | International ME/CFS Conference 2025: Changed patterns of blood metabolites

18:57

Christian Puta | International ME/CFS Conference 2025: Mechanisms of Post-Exertional Malaise (PEM)

13:43

Rob Wust | International ME/CFS Conference 2025: Skeletal muscle alteration in Long COVID and ME/CFS

18:08

David Systrom | International ME/CFS Conference 2025: Circulatory dysfunction in ME/CFS

04:15

Guido Cammà | International ME/CFS Conference 2025: Functional Connectivity Alterations in ME/CFS

03:26

Wiebke Löhden | International ME/CFS Conference 2025: Reduced Abundance of Gut Bacteria in ME/CFS

05:44

Lorenz Mihatsch | International ME/CFS Conference 2025: Handgrip Strength in Children with ME/CFS

04:23

Anouk Slaghekke | International ME/CFS Conference 2025: Skeletal Muscle in ME/CFS and Post-COVID

03:17

Christian Puta | International ME/CFS Conference 2025: Raman Spectroscopic Profiling of Immune Cells

15:58

Kristian Sommerfelt | International ME/CFS Conference 2025: Severe, and very severe ME/CFS in Norway

15:54

Bernhard Wörmann | International ME/CFS Conference 2025: Long/Post-COVID Off-Label-Use of Drugs

16:27

Michael Stingl | International ME/CFS Conference 2025: Clinical care for ME/CFS

11:39

Fridbjörn Sigurdsson | International ME/CFS Conference 2025: The Akureyri Clinic

15:54

Kathryn Hoffmann | International ME/CFS Conference 2025: Reference Center for Post-viral Syndromes

12:17

Uta Behrends | International ME/CFS Conference 2025: PEDNET-LC

23:01

Carmen Scheibenbogen | International ME/CFS Conference 2025: Where have we made progress?

21:20

Klaus Wirth | International ME/CFS Conference 2025: Exercise Intolerance and Therapeutic Strategy

21:24

David Putrino | International ME/CFS Conference 2025: Infection-Associated Chronic Illnesses (IACIs)

06:10

Carmen Scheibenbogen | International ME/CFS Conference 2025: Welcome

10:20

Wolfram Döhner | ME/CFS Symposium 2025: BMBF-Forschungsverbund - VADYS-ME

11:21

Elisabeth Schieffer | ME/CFS Symposium 2025: BMBF-Forschungsverbund – MIRACLE

10:21

Christian Puta | ME/CFS Symposium 2025: BMBF-Forschungsverbund - BioSig-PEM

11:47

Birgit Sawitzki | ME/CFS Symposium 2025: BMBF-Forschungsverbund - CURE-ME

10:07

Anna Brock | ME/CFS Symposium 2025: G-BA Innovationsfond-Versorgungsstudie – LCovB

10:57

Jakob Johne | ME/CFS Symposium 2025: BMG-Versorgungsstudie – GRACI

12:37

Meike Dirks | ME/CFS Symposium 2025: BMG-Versorgungsstudie – ACCESS

17:35

Kirsten Wittke | ME/CFS Symposium 2025: BMG-Versorgungsstudie - PAIS Care Berlin

14:26

Uta Behrends | ME/CFS Symposium 2025: BMG-Versorgungsstudie - PEDNET-LC

17:22

Karl Lauterbach | ME/CFS Symposium 2025: Vorwort

13:08

Jörg Heydecke | ME/CFS Symposium 2025: Gesellschaftliche Kosten von ME/CFS & Long COVID

05:19

Still Loud Project feat. Dagmar Lauschke: WAS WIR WOLLEN

01:00

Wie ME/CFS Fans und Athleten aus der Kurve reißt